Calquence 100 mg, Hartkapseln

7680677900013 CH-67790 Kapseln

Associated product:

CALQUENCE caps 100 mg 60 pce
Calquence 100 mg, Hartkapseln
Calquence 100 mg, Hartkapseln
Calquence 100 mg, Hartkapseln
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
02/12/2024
Summary of Product Characteristics
Français
02/12/2024
Summary of Product Characteristics
Italien
02/12/2024
Patient information leaflet
Allemand
23/08/2022
Patient information leaflet
Français
23/08/2022
Patient information leaflet
Italien
23/08/2022

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
67790
Drug name
Calquence, Hartkapseln
Galenic form
KAHA
ATC Code
L01EL02
Authorization status
Z
Dispensing category
A
First authorization
04/03/2021
Authorization expiration date
03/03/2026
IT Number
07.16.1.
Domain
Human medicine
Field of application
chronisch lymphatische Leukämie (CLL)

Package details

Description (FR)
CALQUENCE caps 100 mg 60 pce
Description (DE)
CALQUENCE Kaps 100 mg 60 Stk
Market launch
04/03/2021
Narcotic (BTM)
No